Randomized Controlled Clinical Trial of Sushrutokta Garbhini Paricharya in 6th and 7th Month of Pregnancy

Pregnancy is a critical period for both mother and child, and culturally appropriate antenatal care can improve outcomes. In Ayurveda, Garbhini Paricharya — prenatal regimen — is mandated to ensure healthy fetal growth and maternal well-being. Classical texts prescribe month-wise dietary and lifestyle measures (Masānūmāsika Paṭhya) to nurture the fetus and prevent complications. For instance, Sushruta advises that from conception onward the pregnant woman should remain always cheerful, pure, calm, and avoid toxic stimuli and adverse food patterns. Similarly, Charaka details how each gestational month the fetus grows and stresses maternal resources — e.g., in the 6th month “increase in strength and complexion of fetus develops”. Modern obstetrics likewise emphasizes personalized antenatal care, including nutrition and lifestyle interventions, to support fetal development. However, despite this theoretical convergence, rigorous clinical evaluation of classical Ayurvedic antenatal regimens is scarce. This paper articulates the framework for an RCT of Sushrutokta Garbhini Paricharya during the 6th–7th months of gestation. We integrate Ayurvedic wisdom and biomedical knowledge to: (1) justify the intervention conceptually, (2) design a robust methodological plan, and (3) propose outcome measures. The focus is on developing a high-quality trial protocol foundation – no results or analysis are presented here.

 

Background and Theoretical Foundation

Ayurveda regards pregnancy (Garbhādhāna) as a unique physiological state. A pregnant woman (garbhini) is to be treated as two entities: mother and fetus, with care to nurture Bhūtendriya (the elemental essence) and Ojas (vital substance). The ancient physician Sushruta declared: “As puruṣha (human) is born and grows from āhārarasa, so must the ahāra rasa (nutritive essence) be maintained healthy by the mother; as garbha (fetus) is a small puruṣha, its growth depends on the mother’s nutrition and conduct”. In simple terms, what the mother consumes and experiences directly shapes fetal development. Classical sources thus prescribe Garbhini Paricharya — regimens of ahara (diet), vihara (behavior/exercise), and rasayana (rejuvenation) for each stage of pregnancy.

 

From a theoretical standpoint, Ayurvedic prenatal care aims at three goals: (1) Pāripūrṇatā (completeness) of mother and fetus; (2) Anupaghāta (complication-free pregnancy); and (3) Sukhaprasava (healthy delivery and child). Shloka references highlight the importance of Rasāyana (rejuvenative) substances which are often sweet (madhura), cooling (śīta), and strengthen deha-bala (body strength) and Indriya-bala (sensory potency). For example, (madhura rasa, śita virya, madhura vipāka) compounds that are jīvanīya, bālya, bruṃhana and ojas-vardhana are said to be beneficial in pregnancy. These correspond biomedically to nutrients and herbs that support placental function, fetal organogenesis and maternal tissue growth. In sum, classical theory emphasizes that tailored nutrition and rejuvenation during the 6th–7th months (the transition to viability) is crucial for imparting bala (strength), varṇa (complexion/health) and ojas (vitality) to the fetus while maintaining maternal reserves.

Figure 1 illustrates the conceptual framework. It starts with classical prenatal principles (Garbhini Paricharya concept), leads to the specific intervention

Aim and Objectives

Aim: To conceptually evaluate the effect of Sushrutokta Garbhini Paricharya regimen administered during the 6th and 7th months of gestation on maternal and fetal health parameters (framework only; no actual outcomes are presented here).

 

Primary Objectives:

•         Implement the classical Ayurvedic regimen for gestational months 6–7 in a cohort of pregnant women.

•         Compare maternal well-being (nutrition status, vital parameters) and fetal growth measures between intervention and control groups under an RCT design.

 

Secondary Objectives:

•         Establish measurement protocols for subjective symptoms (appetite, digestion, mood) and objective markers (weight, hemoglobin, ultrasound biometry) aligned with both Ayurvedic outcomes (e.g. bala, varṇa) and biomedical standards.

•         Assess adherence to the regimen and any adverse events (pre-specified safety monitoring).

•         Develop a data analysis plan (statistical framework) to interpret findings in light of the conceptual framework.

 

Hypothesis

Null Hypothesis (H0): There is no difference in maternal or fetal health parameters between pregnant women following Sushrutokta Garbhini Paricharya regimen and those receiving standard care in months 6–7.

 

Alternative Hypothesis (H1): Pregnant women receiving the classical Ayurvedic regimen will show statistically significant improvements in specified maternal (e.g. weight gain, nutritional status) and fetal (e.g. growth velocity, wellbeing) parameters compared to controls.

 

Conceptual Framework

The conceptual model (Figure 1) is built on classical and biomedical premises. At the left, Classical Concept encompasses Ayurvedic goals (Rasayana, Bala, Ojas). This informs the Intervention: month-specific diet (ghee, milk, nourishing gruels, plus Ayurvedic herbs like Shatavari, Bala, Guduchi) and lifestyle (rest, calming activities) stipulated by Sushruta. These interventions are hypothesized to modulate Maternal Physiology: improved nutrition, stable metabolism, reduced stress, enhanced immunity (Vyadhikṣamatva). This in turn supports Fetal Growth: appropriate organ maturation, placental function, and accumulation of budha (essence) and ojas in the fetus. Finally, Measurable Outcomes include both Ayurvedic indicators (e.g. maternal appetite, complexion) and biomedical metrics (weight gain, hemoglobin, ultrasound fetal indices). Thus the chain of causality goes from ideology to quantifiable effect. As one review explains, integrating holistic Ayurvedic care can “enhance pregnancy outcomes and maternal well-being” through defined physiological pathways.

Methodological Framework

 

Study Design: A two-arm, parallel-group RCT. Participants will be randomized 1:1 into Intervention or Control. Randomization uses computer-generated sequences and sealed envelopes to ensure allocation concealment. Blinding is impractical for participants (diet/lifestyle is overt), but outcome assessors (ultrasound technicians, lab personnel) will be blinded to group assignment when possible. The trial will adhere to CONSORT guidelines for design and reporting.

Participants: Inclusion: Pregnant women aged 18–35, singleton pregnancy, at start of 6th month (22–24 weeks by ultrasound), with no major complications. Exclusion: high-risk conditions (e.g. severe hypertension, diabetes, heart disease), multiple gestation, known fetal anomalies, or use of conflicting supplements. Informed consent will be obtained as per ethical norms.

 

Setting: The study will be conducted at a tertiary care obstetric hospital with Ayurvedic collaboration, to ensure both proper monitoring and delivery of classical regimen components.

 

Randomization & Allocation: Random sequence generation (e.g. block randomization) will be prepared by an independent statistician. Allocation will be concealed via opaque envelopes opened sequentially by clinic staff upon enrollment.

 

Interventions:

•         Intervention Group: Will follow Sushruta’s Garbhini Paricharya for months 6–7. Based on classical texts, this includes:

•         Dietary regimen: Morning and evening meals of yavagu (rice gruel) with medicated ghee; milk (preferably goat’s milk if available) with sweet adjuncts; inclusion of nourishing grains (Shashtika rice), fruits (banana, pomegranate), and easily digestible proteins (legumes, paneer). Weekly intake of small amounts of ghee kalpana (medicated ghee) prepared with Rasayana herbs (e.g. Shatavari, Bala, Ashwagandha, Vidari Kanda) known as Garbhaprasadana.

•         Lifestyle regimen: Daily rest periods with relaxation; moderate activity (gentle walking, prenatal yoga) as tolerated; avoidance of fasting, strenuous work, and travel to unclean places (e.g. crematoria). Encouragement of a calm mental state through prayer or meditation.

•         Herbal support: Administration of safe herbal Rasayanas: e.g., Sarsapushpa (Cynodon dactylon) or Guduchi (Tinospora cordifolia) as decoctions, based on classical lists. These are chosen for their balya (strengthening), jitendriya (stress-relieving) and immunomodulatory properties. (Herbal dosing will follow pharmacopeial standards and obstetric safety data.)

•         Control Group: Will receive standard obstetric care only: routine diet advice per national guidelines, iron–folate and calcium supplementation, and antenatal check-ups. They will not receive the specialized Ayurvedic regimen.

 

Regimen Standardization: The intervention is standardized via protocols: weekly menus, recipes, and herbal formulations. A trained Ayurvedic physician will oversee adherence. The regimen is explicitly the one utpanne by Sushruta for 6th–7th months, hence “Sushrutokta Garbhini Paricharya”.

Timeline: Participants will be enrolled at 22–24 weeks (start of 6th month). The intervention will run through 28 weeks (end of 7th month). Visits will occur at baseline (week 22), mid-intervention (week 25), end of intervention (week 28), and follow-ups until delivery (for outcome capture). Data collection points align with routine obstetric schedule.

 

Intervention Framework

The core of Sushrutokta (as per Sushruta Samhita, Sharira Sthana 10) is month-specific. In Sushruta’s own words, “hṛdyaṃ dravaṃ madhuraṃ snigdhaṃ dīpaniyaṃ saṃskṛtaṃ ca bhojanaṃ bhojayet” — she should be fed an agreeable, fluid, predominantly sweet, nourishing and digestive-stimulating diet. For the 6th month specifically, Sushruta recommends medicated ghee or thick gruel (yavagu) in the morning and evening. In the 7th month, he advises milk with specific additives (for example, Virohi Khalva or Gudūcī kṣīra), which are believed to enhance Rasa–Rakṭa (nutritive fluid) for the fetus. These prescriptions will be operationalized: e.g. gaviskhya (soaked cow’s ghee) with herbs in water or milk.

 

Ayurvedic Rasayana is central. Herbs like Asparagus racemosus (Shatavari), Sida cordifolia (Bala), Centella asiatica (Brahmi), Bacopa monnieri, Tinospora cordifolia are classically indicated in pregnancy. Contemporary studies support their adaptogenic and immunomodulatory roles (e.g., Shatavari and Ashwagandha have hematopoietic and stress-modulating effects). We will use a standardized powdered or extract form of selected herbs as prāṣṭha (tablet) or in ghee decoction. Dosages follow Ayurvedic pharmacopeia and modern safety guidelines. The combination is designed to bolster maternal deha-bala (body strength) and ojas without toxicity.

 

Behavioral advice complements diet. Sushruta forbids sleeping on a high bed or with heavy blankets, and advises moderate exercise (gentle massage, unstrained mobility). These non-pharmacological instructions will be taught.

 

All components will be documented in an “Intervention Manual” for replication. Control subjects will be offered general healthy-pregnancy advice (balanced diet, exercise) after study completion to maintain equipoise.

Outcome Measurement Framework

A dual framework of subjective and objective measures will capture the multi-dimensional effects.

•         Subjective (Patient-reported): Maternal well-being questionnaires will assess appetite, digestion, fatigue, sleep quality, mood, and perceived energy (reflecting Ayurvedic bala). Standard scales (e.g. Pregnancy-Unique Quantification of Emesis [PUQE] for nausea, Visual Analog Scale for fatigue) can be used. Traditional Ayurvedic symptoms (e.g. śuklavasanā cleanliness, samgardhahānita indigestion) will be translated into lay terms. The impact on quality of life (per WHOQOL-BREF) is also noted.

 

Objective (Clinical/Biochemical):

•         Maternal anthropometry: weight gain from enrollment to 28 weeks, Body Mass Index (BMI) progression.

•         Hematology: Hemoglobin, RBC indices (to reflect rakta-pushti), serum proteins (albumin as nutrition marker), and immunoglobulins (IgG, IgM) as per Patankar et al..

•         Biochemistry: Serum calcium, vitamins (D, B12 if indicated), to monitor nutritional adequacy.

•         Maternal vitals: Blood pressure (since hypertensive disorders are a key risk), blood sugar.

•         Ultrasound fetal biometry: Biparietal diameter, femur length, abdominal circumference measured at baseline and 28 weeks to assess fetal growth rate.

•         Doppler studies: Optional uterine artery Doppler to gauge placental perfusion (maternal circulation effects).

•         Birth outcomes (follow-up): Though outside the 7-month frame, capturing birth weight, gestational age at delivery, and Apgar score can contextualize fetal impact.

These align with outcomes in comparable studies. For example, Patankar et al. used maternal weight, hemoglobin and Ig levels, and GI symptom scores, while Supriya et al. (2026) tracked hemoglobin and stress/sleep scales. We will predefine primary and secondary endpoints (e.g. primary: mean maternal weight gain; secondary: change in hemoglobin, fetal head circumference). Outcomes will be measured by blinded assessors. An outcome table (Table 1) summarizes these metrics by group.

 

 

 

 

 

 

 

 

Table 1. Outcome Assessment Framework (Subjective & Objective Parameters)

(Source: Adapted conceptually from Patankar et al. (2019) and Supriya et al. (2026) RCTs, integrating subjective Ayurvedic parameters.)

 

Statistical Framework

An a priori sample size calculation will be performed (e.g. to detect a clinically meaningful difference of 0.5 kg in mean weight gain with 80% power, α=0.05). Though no actual data are presented, the plan is to use an intention-to-treat analysis. Continuous outcomes (weight, lab values) will be compared by t-tests or ANOVA; categorical outcomes (symptom improvement rates) by chi-square tests. Repeated measures ANOVA or mixed models may analyze trends over time. Effect sizes (mean differences, 95% confidence intervals) will be reported. Missing data will be handled by last observation carried forward or multiple imputation, per CONSORT advice. Statistical software (SPSS or R) will be used, and significance set at p<0.05. No interim analysis or stopping rules are planned given the short timeframe, but an independent DSMB could be convened if needed.

 

Ethical Framework

Research involving pregnant women requires special safeguards. This study will adhere to international and national ethical standards. Following the ICMR Guidelines, we recognize pregnant women’s right to participate in research relevant to their health and ensure benefits justify any risk. The protocol will be approved by an Institutional Ethics Committee. Key ethical points:

•         Informed Consent: Women will receive detailed verbal and written explanations (in local language) about the trial’s purpose, procedures, benefits, and potential risks. They must consent voluntarily, with no coercion. Their right to withdraw at any time will be emphasized.

•         Risk Minimization: The intervention components (diet, herbal Rasayanas) are based on long-standing traditional use with known safety profiles. We will exclude any herbs contraindicated in pregnancy. The regimen avoids vigorous treatments and known teratogens. Maternal and fetal status will be continuously monitored; any adverse event prompts immediate medical care or withdrawal.

•         Benefit-Risk Assessment: As per ICMR, pregnant women should be included when research addresses pregnancy-related health. Here, potential benefits include improved maternal nutrition and fetal growth. Risks are minimal: dietary changes or mild herbs. We will ensure that any uncertainty is clearly communicated.

•         Confidentiality: Participant data will be coded to maintain privacy. Only the research team will access records.

•         Compliance with Guidelines: The trial will be registered in the Clinical Trials Registry (India). It will follow the Declaration of Helsinki’s principles and ICMR ethics guidelines (2017). These require careful benefit-risk balance: we are studying a traditional regimen (with physiological rationale) which is not expected to harm the fetus. Regular obstetric care and emergency support will be available.

By these measures, we align with ethical imperatives that encourage inclusion of pregnant women in relevant research (rather than excluding them) when well-justified.

 

Expected Scientific Contribution

This study’s framework has several anticipated contributions. Conceptually, it articulates how an ancient regimen can be integrated into evidence-based practice. By mapping Ayurvedic outcomes (ojas, bala, varṇa) onto biomedical measures, it builds a bridge between paradigms. Methodologically, it exemplifies how to design a rigorous trial for a multi-component lifestyle intervention – a non-pharmacological approach akin to WHO’s holistic ANC recommendations. If the regimen proves beneficial (as hypothesized), it would provide the first high-level evidence that Sushrutokta Garbhini Paricharya improves maternal and fetal health. Even if findings are equivocal, the study will clarify which aspects (diet, herbs, lifestyle) are most impactful, guiding future research.

Clinically, validated results could inform antenatal guidelines, encouraging integrative care strategies. For Ayurveda, demonstrating efficacy of Rasayana in pregnancy would stimulate further investigations and acceptance. Theoretically, success would substantiate classical maxims like “deerghayu, medha, arogyam smriti pracura” (long life, intellect, health, memory) being transmitted to the child through Rasayana supplementation.

In sum, this trial aims to contribute scientific rigor to Ayurveda’s prenatal wisdom, potentially improving maternal care worldwide by blending holistic and allopathic principles.